RTI.V - Radient Technologies Inc.

TSXV - TSXV Delayed Price. Currency in CAD
0.1550
0.0000 (0.00%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close0.1550
Open0.1550
Bid0.1450 x N/A
Ask0.1500 x N/A
Day's Range0.1450 - 0.1550
52 Week Range0.1250 - 0.8000
Volume332,979
Avg. Volume716,985
Market Cap48.822M
Beta (5Y Monthly)1.85
PE Ratio (TTM)N/A
EPS (TTM)-0.1000
Earnings DateAug. 31, 2020 - Sep. 04, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Radient Technologies Inc. Announces Receipt of Sales License, Launch of 2.0 Product Offerings And Supply Agreement with Premium 5 Ltd.

    Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), a manufacturer of high quality cannabinoid-based formulations and products, has received a Health Canada license amendment for the sale of cannabis extracts, cannabis edibles and cannabis topicals. This license, which allows for the sale of all three categories of extracted products, is a significant milestone in commercializing the Company’s product offerings and launching its 2.0 product portfolio. Radient is also pleased to announce that it has entered into a manufacturing and service agreement with Premium 5 Ltd. (“P5”) for multiple products under its brand of premium concentrates.

  • Trade Alert: The CFO and Administration & Finance Officer Of Radient Technologies Inc. (CVE:RTI), Prakash Hariharan, Has Just Spent CA$86k Buying 75% More Shares
    Simply Wall St.

    Trade Alert: The CFO and Administration & Finance Officer Of Radient Technologies Inc. (CVE:RTI), Prakash Hariharan, Has Just Spent CA$86k Buying 75% More Shares

    Even if it's not a huge purchase, we think it was good to see that Prakash Hariharan, the CFO and Administration...

  • GlobeNewswire

    Radient Technologies Inc. Announces bioU Products Are Now Available at Medical Cannabis by Shoppers and Completion of Previously Announced Debt Settlement and Shares for Services

    Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), a global commercial manufacturer of high quality cannabinoid-based ingredients, formulations and products, announces that its recently launched bioU branded products are now available through Medical Cannabis by Shoppers, a subsidiary of Shoppers Drug Mart Inc. The bioU brand was created exclusively for Medical Cannabis by Shoppers and is now available across Canada. The Company has also received the approval from the TSX Venture Exchange (the “TSXV”) for a series of shares for debt agreements with various of its creditors, which was previously announced in a press release dated May 8, 2020 under the terms and conditions noted below.

  • GlobeNewswire

    Radient Announces Successful Closing of its Equity Offering for Gross Proceeds of $5,750,000

    Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF) is pleased to announce that it has closed its public equity financing initially announced on May 20, 2020. The Company issued 28,750,000 units (the “Units”) of the Company (which includes 3,750,000 Units issued pursuant to the exercise in full of the over-allotment option) at a price of $0.20 per Unit (the “Offering Price”) for aggregate gross proceeds of $5,750,000 (the “Offering”). The Offering was completed by Eight Capital (the “Agent”) as sole agent.

  • GlobeNewswire

    Radient Technologies Inc. Receives TSXV Approval to Extend Warrants

    Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), a global commercial manufacturer of high quality cannabinoid-based ingredients, formulations and products, announces that it has received the approval from the TSX Venture Exchange to extend the term of 3,051,310 warrants originally scheduled to expire on June 2, 2020 and 5,872,382 warrants originally scheduled to expire on June 22, 2020 (the “Warrants”) to June 2, 2021 and June 22, 2021, respectively. The Warrants were originally issued pursuant to private placements of units completed by the Company on December 2, 2016 and December 22, 2016. The new expiry date for these warrants is June 2, 2021 and June 22, 2021, respectively.

  • GlobeNewswire

    Radient Technologies Inc. Launches bioU, a Brand of High Quality Cannabis Extract Formulations Exclusively for Medical Cannabis by Shoppers

    Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), a global manufacturer of high quality cannabinoid-based ingredients, formulations and products, is pleased to announce the launch of bioU, a scientifically formulated brand exclusively sold to Medical Cannabis by Shoppers™ (“Shoppers”), a subsidiary of Shoppers Drug Mart Inc., and available across Canada. Radient’s first products released under the bioU label will be the Uspray series of high quality, scientifically formulated oral cannabis sprays.

  • GlobeNewswire

    Radient Technologies Announces $5 Million Equity Offering

    Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF) is pleased to announce a proposed offering of 25,000,000 units (the “Units”) at an offering price of $0.20 per Unit (the “Issue Price”), for aggregate gross proceeds of up to $5,000,000 (the “Offering”). The Units will be offered on a best efforts basis by Eight Capital, as agent for the Company (the “Agent”), pursuant to a prospectus supplement to Radient’s base shelf prospectus dated January 21, 2020 (collectively, the “Prospectus”). BDO Canada LLP is acting as Radient’s financial advisor in connection with the Offering.

  • CNW Group

    IIROC Trading Resumption - RTI

    IIROC Trading Resumption - RTI

  • GlobeNewswire

    Radient Technologies Inc. Announces Collaboration on the Development of Anti-Viral Products and Files Patent Application Covering Cannabinoid Based Compositions for the Mitigation and Protection from Viruses

    Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), a commercial manufacturer of high quality cannabinoid-based ingredients, formulations and products, announces that it has filed a provisional patent application covering the use of a combination of cannabinoids, terpenes and zinc (the “Formulations”) as a means of preventing infection of coronavirus, mitigating the symptoms of coronavirus, and lowering infectiousness of Covid-19 patients, with the goal of reducing hospitalizations and intensive care unit requirements. Additionally, the Company announces that it will lead a collaboration with two US based groups, IntuitiveX (“IntuitiveX”) and ipCapital Group (“ipCapital”), to explore the development of new anti-viral products using the Formulations.

  • Does Radient Technologies Inc. (CVE:RTI) Have A High Beta?
    Simply Wall St.

    Does Radient Technologies Inc. (CVE:RTI) Have A High Beta?

    Anyone researching Radient Technologies Inc. (CVE:RTI) might want to consider the historical volatility of the share...

  • CNW Group

    IIROC Trading Halt - RTI

    IIROC Trading Halt - RTI

  • GlobeNewswire

    Radient Technologies Inc. Announces Shares for Debt Arrangements

    Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), a global commercial manufacturer of high quality cannabinoid-based ingredients, formulations and products, announces that it has entered into a series of shares for debt agreements with various of its creditors under the terms and conditions noted below. The Company has agreed to issue 3,781,073 units to a number of third party creditors in exchange for the settlement of $623,877 of amounts owed by the Company. Each unit will have a deemed value of $0.165 per unit and each unit will include one share and one-half of one common share purchase warrant.

  • GlobeNewswire

    Radient Technologies Inc. Applies to Extend Warrants

    Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), a global commercial manufacturer of high quality cannabinoid-based ingredients, formulations and products, has applied to the TSX Venture Exchange (the “TSXV”) to extend the term of 1,070,712 warrants originally scheduled to expire on April 14, 2020 (the “Warrants”) to April 14, 2021. The Warrants were originally issued pursuant to a private placement of units completed by the Company on October 14, 2016. The exercise price of the Warrants will remain at CAD $0.25.

  • GlobeNewswire

    Radient Announces the Initiation of an At-the-Market Equity Program and Provides an Update on Initiatives to Meet Customer Demand During COVID-19 Pandemic, Financing Activities and Liquidity

    Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF) announces that the Company has established an at-the-market equity program (the “ATM Program”). The Company also announces that it is actively reviewing its operations in response to guidance from governmental and health authorities with a view to limiting the spread of the virus that causes COVID-19, and also wishes to provide an update on its current liquidity and financing activities. The ATM Program will allow the Company to issue up to $9.4 million worth of common shares from treasury (“Common Shares”) to the public from time to time at prevailing market prices through the TSX Venture Exchange (“TSXV”) or any other marketplace on which the Common Shares are listed, quoted or otherwise traded in Canada.

  • GlobeNewswire

    Allied Corp. and Radient Technologies Inc. Announce Agreement to Facilitate Premium Quality CBD Products to be Sold in Canada

    Allied Corp. ("Allied" or the "Company") (OTCQB: ALID), an international medical cannabis company focused on creating and providing targeted cannabinoid health solutions to address today’s medical issues, and Radient Technologies Inc. (“Radient”) (TSX Venture: RTI; OTCQX: RDDTF), a global commercial manufacturer of high quality cannabinoid-based ingredients, formulations and products, are pleased to announce they have signed a definitive agreement (the “Agreement”) as part of a three way agreement with the Dhaliwal Group (“Dhaliwal”) to manage the supply chain, manufacturing and sale of high quality CBD distillate and isolate. Under the terms of the Agreement, Allied will facilitate the supply and purchase of high quality CBD distillate and isolate between licensed cultivators and licensed buyers.

  • Shareholders Are Thrilled That The Radient Technologies (CVE:RTI) Share Price Increased 290%
    Simply Wall St.

    Shareholders Are Thrilled That The Radient Technologies (CVE:RTI) Share Price Increased 290%

    The last three months have been tough on Radient Technologies Inc. (CVE:RTI) shareholders, who have seen the share...

  • GlobeNewswire

    Radient Technologies Inc. Receives License Amendment from Health Canada for its Edmonton II Facility and Closes First Tranche of its Previously Announced Debenture Financing

    Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), a global commercial manufacturer of high quality cannabinoid-based ingredients, formulations and products, is pleased to announce that Health Canada has approved the Company’s application to amend its existing Standard Processors License to include its Edmonton II facility for the processing of cannabis materials. Radient’s Edmonton II Facility (“Edmonton II”), which the Company has retrofitted to accommodate the extraction and downstream processing of CBD from hemp, was designed to process both cannabis and hemp materials to produce high quality cannabinoid extracts.

  • GlobeNewswire

    Radient Technologies Inc. Reports Record Revenue and Record Gross Profit for the Third Quarter of Fiscal 2020

    Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), a global commercial manufacturer of high quality cannabinoid-based ingredients, formulations and products, is pleased to report its financial results for the third quarter of its fiscal year 2020, ended December 31, 2019. The financial statements and Management’s Discussion & Analysis are available under the Company’s profile at www.SEDAR.com.

  • GlobeNewswire

    Radient Technologies Inc. Signs Supply Agreement with Medical Cannabis by Shoppers, a subsidiary of Shoppers Drug Mart Inc., for the Formulation and Manufacturing of Exclusive Branded Cannabis Products

    Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), a global manufacturer of high quality cannabinoid-based ingredients, formulations and products, is pleased to announce it has entered into a supply agreement (the “Agreement”) with Medical Cannabis by Shoppers, the online medical cannabis platform of leading Canadian pharmacy retailer Shoppers Drug Mart (“Shoppers”). Under the terms of the Agreement, Radient will utilize its proprietary extraction and downstream processing platform to create a variety of cannabinoid formulations under a brand that will be sold exclusively to patients of Medical Cannabis by Shoppers.

  • GlobeNewswire

    Radient Technologies Inc. Announces up to CAD $15.4 Million in Debenture Financings and Provides Corporate Update

    Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), a global commercial manufacturer of high quality cannabinoid-based ingredients, formulations and products, is pleased to announce a total financing package of up to CAD $15,400,000 through the issuance of up to $10.4 million of unsecured convertible notes (the “Notes”) and up to $5 million of unsecured debentures (the “Debentures”). Attached to the Notes will be share purchase warrants with the terms described below (the “Warrants”).

  • GlobeNewswire

    Radient Technologies Inc. Announces Changes to its Board of Directors

    Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), a global commercial manufacturer of high quality cannabinoid-based ingredients, formulations and products, announces the following changes to its Board of Directors, effective today. Radient is pleased to announce that Health Canada has approved the addition of Ms. Jocelyne F. Lafrenière and Mr. Yves Gougoux to its Board of Directors, effective today.

  • Aurora Cannabis Announces Appointment of Two New Independent Directors
    CNW Group

    Aurora Cannabis Announces Appointment of Two New Independent Directors

    Friedmann and Detlefsen Bring Significant Experience in Consumer Products and Marketing NYSE | TSX : ACB EDMONTON , Feb. 6, 2020 /CNW/ -   Aurora Cannabis Inc. (the "Company" or "Aurora") ...

  • Aurora Cannabis Announces CEO Retirement and Succession, Board of Directors Expansion, and Business Transformation Plan
    CNW Group

    Aurora Cannabis Announces CEO Retirement and Succession, Board of Directors Expansion, and Business Transformation Plan

    EDMONTON , Feb. 6, 2020 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, today announced a CEO succession and Board expansion; the latter of which is detailed in a separate announcement released this afternoon. The Company also announced a business transformation plan that better aligns selling, general & administrative expenses, and capital expenditures with current market conditions.

  • Aurora Cannabis Receives EU GMP Certification for its Aurora River Facility
    CNW Group

    Aurora Cannabis Receives EU GMP Certification for its Aurora River Facility

    Achievement increases total production capacity available to serve international medical markets by 230% Brings Aurora's total number of EU GMP certified Canadian production facilities to 3 Pharmacies ...

  • Is Radient Technologies Inc.'s (CVE:RTI) CEO Salary Justified?
    Simply Wall St.

    Is Radient Technologies Inc.'s (CVE:RTI) CEO Salary Justified?

    Denis Taschuk became the CEO of Radient Technologies Inc. (CVE:RTI) in 2011. This report will, first, examine the CEO...